WEST PHARMACEUTICAL SERVICES INC financial data

Symbol
WST on NYSE
Location
Exton, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 23 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 281% % 4%
Quick Ratio 70% % 2.8%
Debt-to-equity 35% % 2.9%
Return On Assets 13% % -6.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71,943,412 shares -0.66%
Common Stock, Shares, Outstanding 71,900,000 shares -0.83%
Entity Public Float $23,900,000,000 USD -15%
Common Stock, Value, Issued $18,800,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 72,200,000 shares -0.82%
Weighted Average Number of Shares Outstanding, Diluted 72,600,000 shares -1.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $695,400,000 USD -3%
Revenue from Contract with Customer, Excluding Assessed Tax $3,017,900,000 USD 4.9%
Research and Development Expense $71,000,000 USD 2.9%
Operating Income (Loss) $587,900,000 USD 2.9%
Nonoperating Income (Expense) $17,600,000 USD 28%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $604,300,000 USD 4.5%
Income Tax Expense (Benefit) $125,100,000 USD 19%
Net Income (Loss) Attributable to Parent $491,700,000 USD -1.6%
Earnings Per Share, Basic 6 USD/shares -0.29%
Earnings Per Share, Diluted 6 USD/shares 0.15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $628,500,000 USD 28%
Accounts Receivable, after Allowance for Credit Loss, Current $625,000,000 USD 19%
Inventory, Net $438,000,000 USD 9.2%
Other Assets, Current $131,800,000 USD -1.8%
Assets, Current $1,823,300,000 USD 18%
Deferred Income Tax Assets, Net $27,900,000 USD -26%
Property, Plant and Equipment, Net $1,740,600,000 USD 11%
Operating Lease, Right-of-Use Asset $97,800,000 USD -9.4%
Intangible Assets, Net (Excluding Goodwill) $8,900,000 USD -28%
Goodwill $110,600,000 USD 1.7%
Other Assets, Noncurrent $75,800,000 USD 9.4%
Assets $4,105,800,000 USD 12%
Accounts Payable, Current $255,800,000 USD 14%
Liabilities, Current $635,400,000 USD 23%
Deferred Income Tax Liabilities, Net $22,800,000 USD 143%
Operating Lease, Liability, Noncurrent $73,500,000 USD -11%
Other Liabilities, Noncurrent $75,300,000 USD 13%
Liabilities $1,054,300,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $102,300,000 USD 25%
Retained Earnings (Accumulated Deficit) $4,262,400,000 USD 11%
Stockholders' Equity Attributable to Parent $3,051,500,000 USD 11%
Liabilities and Equity $4,105,800,000 USD 12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $129,400,000 USD 9.5%
Net Cash Provided by (Used in) Financing Activities $147,000,000 USD 46%
Net Cash Provided by (Used in) Investing Activities $71,300,000 USD 21%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 75,300,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $80,400,000 USD 68%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $628,500,000 USD 28%
Deferred Tax Assets, Valuation Allowance $12,800,000 USD -17%
Operating Lease, Liability $94,900,000 USD -7.1%
Depreciation $39,100,000 USD 13%
Payments to Acquire Property, Plant, and Equipment $71,300,000 USD -21%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $525,700,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid $106,900,000 USD -8.2%
Property, Plant and Equipment, Gross $3,232,900,000 USD 8.1%
Operating Lease, Liability, Current $21,400,000 USD 7.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $18,400,000 USD -8.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $25,400,000 USD 9.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12,000,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $16,600,000 USD 7.1%
Deferred Tax Assets, Operating Loss Carryforwards $6,100,000 USD -39%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3,000,000 shares 0%
Unrecognized Tax Benefits $43,600,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Four $12,700,000 USD -9.9%
Operating Lease, Payments $6,100,000 USD 15%
Additional Paid in Capital $0 USD -100%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $165,100,000 USD 7%
Deferred Tax Assets, Net of Valuation Allowance $93,800,000 USD -4.5%
Share-based Payment Arrangement, Expense $21,400,000 USD 35%
Interest Expense $700,000 USD -76%